I won't give them a year...been here already since last summer with no results. I think they've had enough time since they announced the priorty patent application on their COVID drug to deliver more than just lame PRs. I'm waiting until Jan end and if no significant movement or announcements by that time, will look to exit first opportunity I get in the next run over or close to my WA. I was even considering avg down from where I am now given the <$.02 price, but still not confident enough in this to throw any more money at it. If I was investing from point 0 today, I might take a smaller position than what I have now given the current price..speculating on potential upside to 1.5X or so in the next run which is possible in the short run. I just don't believe this will ever amount to a $1+ per share stock anymore. But like I said, every investor needs to make their own judgement and timeline
BTW...send them an e-mail today requesting some ballpark idea of their timeline for mice studies/announcements...no answer. Not surprised anymore
News 
Market Data 
Discover 
